NCT04226521View on ClinicalTrials.gov

Extracorporeal Photopheresis and Early Cardiac Graft Vasculopathy

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

October 17, 2023

Study Completion Date

October 17, 2023

Conditions
Cardiac Allograft VasculopathyHeart Transplant Rejection
Interventions
PROCEDURE

Extracoropreal photopheresis

Patients who sign informed consent form undergo prophylactic extracorporeal photopheresis after heart transplant according to predetermined protocol

Trial Locations (1)

10000

UHC Zagreb, Zagreb

All Listed Sponsors
collaborator

University of Zagreb

OTHER

lead

Bosko Skoric

OTHER

NCT04226521 - Extracorporeal Photopheresis and Early Cardiac Graft Vasculopathy | Biotech Hunter | Biotech Hunter